Cargando...

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations are the second most common oncogenic driver event in non-small cell lung cancer (NSCLC). Classical activating mutations (exon 19 deletions and the L858R point mutation) comprise the vast majority of EGFR mutations and are well defined as strong predi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Semin Cancer Biol
Main Authors: Harrison, Peter T., Vyse, Simon, Huang, Paul H.
Formato: Artigo
Idioma:Inglês
Publicado: Academic Press 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083237/
https://ncbi.nlm.nih.gov/pubmed/31562956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.09.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!